Literature DB >> 23197079

Evaluation of cardiac function by magnetic resonance imaging during the follow-up of patients with Kawasaki disease.

Carline E Tacke1, Soha Romeih, Irene M Kuipers, Anje M Spijkerboer, Maarten Groenink, Taco W Kuijpers.   

Abstract

BACKGROUND: Although histopathologic studies suggest persistent myocardial abnormalities after Kawasaki disease (KD), the long-term effects on cardiac function remain to be revealed. We investigated biventricular volumes, function, and the presence of myocardial fibrosis by cardiac magnetic resonance imaging during long-term follow-up of KD. METHODS AND
RESULTS: Sixty patients with a history of KD (mean age, 16.9 years; 67% men; median interval after KD onset, 11.6 years) and 20 healthy control subjects (mean age, 17.9 years; 55% men) 12 to 24 years of age underwent cardiac magnetic resonance imaging. Biventricular end-diastolic volume, end-systolic volume, stroke volume, and ejection fraction were determined. Volumetric measurements were indexed for body surface area. Late contrast enhancement was used to detect areas of myocardial fibrosis. Biventricular volumes and function did not differ significantly between patients and control subjects. There were also no significant differences between patients with and without a history of left ventricular dysfunction resulting from KD-associated myocarditis or between patients with and without coronary artery aneurysms. Only those with prior ischemic heart disease had a significantly lower left ventricular ejection fraction compared with unaffected KD cases (left ventricular ejection fraction, 51% versus 57%; P=0.012). Late contrast enhancement was observed in only 2 patients with severe coronary artery aneurysms and was typical for myocardial infarction.
CONCLUSIONS: In this cardiac magnetic resonance imaging study evaluating the cardiac function of patients with KD at long-term follow-up, we did not observe a difference in cardiac function between KD patients and control subjects, except for a subgroup of patients with ischemic heart disease as a result of severe coronary artery pathology.

Entities:  

Mesh:

Year:  2012        PMID: 23197079     DOI: 10.1161/CIRCIMAGING.112.976969

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  17 in total

Review 1.  Utility of late gadolinium enhancement in pediatric cardiac MRI.

Authors:  Maryam Etesami; Robert C Gilkeson; Prabhakar Rajiah
Journal:  Pediatr Radiol       Date:  2015-12-30

2.  Stress perfusion magnetic resonance imaging to detect coronary artery lesions in children.

Authors:  Chodchanok Vijarnsorn; Michelle Noga; Daryl Schantz; Dion Pepelassis; Edythe B Tham
Journal:  Int J Cardiovasc Imaging       Date:  2016-12-20       Impact factor: 2.357

Review 3.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  Circ Cardiovasc Imaging       Date:  2022-06-21       Impact factor: 8.589

Review 4.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease : Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-21       Impact factor: 6.903

Review 5.  Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk.

Authors:  Durga Prasanna Misra; Sajjan N Shenoy
Journal:  Rheumatol Int       Date:  2016-02-17       Impact factor: 2.631

Review 6.  Dissecting Kawasaki disease: a state-of-the-art review.

Authors:  S M Dietz; D van Stijn; D Burgner; M Levin; I M Kuipers; B A Hutten; T W Kuijpers
Journal:  Eur J Pediatr       Date:  2017-06-27       Impact factor: 3.183

7.  Myocardial Strain and Strain Rate in Kawasaki Disease: Range, Recovery, and Relationship to Systemic Inflammation/Coronary Artery Dilation.

Authors:  Benjamin Frank; Jesse Davidson; Suhong Tong; Blake Martin; Heather Heizer; Marsha S Anderson; Mary P Glode; Samuel R Dominguez; Pei-Ni Jone
Journal:  J Clin Exp Cardiolog       Date:  2016-04-21

8.  Cardiovascular imaging in children and adults following Kawasaki disease.

Authors:  S M Dietz; C E Tacke; I M Kuipers; A Wiegman; R J de Winter; J C Burns; J B Gordon; M Groenink; T W Kuijpers
Journal:  Insights Imaging       Date:  2015-07-27

Review 9.  Controversies in diagnosis and management of Kawasaki disease.

Authors:  Rakesh Kumar Pilania; Dharmagat Bhattarai; Surjit Singh
Journal:  World J Clin Pediatr       Date:  2018-02-08

10.  Importance of blood pressure control in Kawasaki disease with expanded multiple giant coronary aneurysms with a 32 mm maximum diameter: a case report.

Authors:  Yuji Moritoh; Masahiro Kamada; Shinsaku Matsumoto; Koji Kido
Journal:  Eur Heart J Case Rep       Date:  2021-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.